MENU

Fox Chase Cancer Center News

Dr. Bob Beck
September 17, 2018

Fox Chase Cancer Center’s J. Robert Beck Receives West Oak Lane Charter School Community Champion Award

PHILADELPHIA (September 17, 2018)— On September 20, 2018, J. Robert Beck, MD, Senior Vice President and Deputy Cancer Center Director at Fox Chase Cancer Center, will receive the West Oak Lane Charter School Community Champion Award, in recognition of Dr. Beck’s support of WOLCS’s STEM program.

Paws for the Caws 2018
September 11, 2018

Fox Chase Cancer Center Hosts 19th Annual Paws for the Cause Charity Dog Walk

PHILADELPHIA (September 11, 2018) – This one-mile walk around Fox Chase Cancer Center’s main campus is a fundraiser for pancreatic cancer research and the postdoctoral research program. Participants will enjoy a variety of vendors, professional pet photos, animal rescue organizations, entertainment, refreshments, contests, and prizes.

September 10, 2018

Presence or Absence of Colorectal Adenomas Influences Efficacy of Chemoprevention

PHILADELPHIA (September 10, 2018)— Chemoprevention was effective in reducing the incidence of colorectal cancer in a new study, but the therapies worked differently depending on whether mice presented with or without benign tumors at the time the intervention started. 

Alana O’Reilly, PhD
September 10, 2018

Balancing Diet-Responsive Signaling Determines Stem Cell Lifespan

PHILADELPHIA (September 6, 2018) – Researchers at Fox Chase Cancer Center have demonstrated for the first time how two diet-dependent signaling pathways fit together to control the health and lifespan of stem cells. Their work shows that manipulating the balance between these pathways can influence how long stem cells live and how long they can reproduce.

Dr. Boumber
August 29, 2018

Yanis Boumber Receives R21 Grant From National Cancer Institute to Study Drug Resistance in Lung Cancer

PHILADELPHIA (August 29, 2018)—Yanis Boumber, MD, PhD, assistant professor in the Department of Hematology/Oncology, has been awarded a R21 grant from the National Cancer Institute to support research on non-small cell lung cancer.

Shannon Lynch
August 29, 2018

Shannon Lynch Receives Research Grant from the American Cancer Society

PHILADELPHIA (August 29, 2018)— Shannon Lynch, PhD, MPH, assistant professor in the Cancer Prevention and Control Program at Fox Chase Cancer Center, has received a grant from the American Cancer Society to support her efforts to reduce racial disparities in prostate cancer.

Sergey Grivennikov
August 29, 2018

Sergey Grivennikov Receives National Cancer Institute R01 Grant for Colorectal Cancer Research

PHILADELPHIA (August 29, 2018)— Sergey Grivennikov, PhD, assistant professor in the Cancer Prevention and Control Program at Fox Chase Cancer Center, has received a R01 grant from the National Cancer Institute to support research on the connection between inflammation and colorectal cancer. The grant will provide approximately $280,000 per year over five years.

Dr. Chernoff
August 27, 2018

Small Molecule Pak 1 Inhibitors May be an Effective Therapy for Colorectal Cancer

PHILADELPHIA (August 27, 2018) – A new study suggests that targeting Group I p21-activated kinases (Paks) with small-molecule inhibitors could be a promising therapeutic approach in colorectal cancer. Researchers led by Jonathan Chernoff, MD, PhD  designed a transgenic mouse model that conditionally expresses an inhibitory peptide to block the catalytic function of Group I Paks, and noted its efficacy in reducing adenomas and impeding progression to carcinomas. 

Pages

Connect with Fox Chase